Literature DB >> 33711963

Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction: a randomized controlled trial.

Linlin Fan1, Yingying Su2, Yan Zhang1, Hong Ye1, Weibi Chen1, Gang Liu1.   

Abstract

BACKGROUND: The effect of hypothermia on large hemispheric infarction (LHI) remains controversial. Our study aimed to explore the therapeutic outcomes of decompressive craniectomy (DC) combined with hypothermia on LHI.
METHODS: Patients were randomly divided into three groups: the DC group, the DC plus head surface cooling (DCSC) group and the DC plus endovascular hypothermia (DCEH) group. The DC group was maintained normothermia. The DCSC group received 24-h ice cap on the head for 7 days. While the DCEH group were given endovascular hypothermia (34 °C). Mortality and modified Rankin Scale (mRS) score at 6 months were evaluated.
RESULTS: Thirty-four patients were included in the study. Mortality of the DC, DCSC and DCEH groups at discharge were 22.2% (2/9), 0% (0/14) and 9.1% (1/11), respectively. However, it increased to 44.4% (4/9), 21.4% (3/14) and 45.5% (5/11) at 6 months, respectively (p = 0.367). Pneumonia (8 cases) was the leading cause of death after discharge. Twelve cases (35.3%) achieved good neurological outcome (mRS 0-3) at 6 months. The proportions of good neurological outcome in the DC, DCSC and DCEH groups were 22.2% (2/9 cases), 42.9% (6/14 cases) and 36.4% (4/11), respectively. The DCSC group seemed to have higher proportion of good outcomes, but there was no significant difference between groups (p = 0.598). Among survivors, endovascular hypothermia had a higher proportion of good outcome (DC group, 2/5 cases, 40.0%; DCSC group, 6/11 cases, 54.5%; DCEH group, 4/6 cases, 66.7%; p = 0.696). The incidence of complications in the DCEH group was higher than those of the DC and DCSC groups (18.9%, 12.0%, and 12.1%, respectively; p = 0.025).
CONCLUSIONS: There is still no evidence to confirm that hypothermia further reduces long-term mortality and improves neurological outcomes in LHI patients with DC. However, there is a trend to benefit survivors from hypothermia. A local cooling method may be a better option for DC patients, which has little impact on systematic complications. TRIAL REGISTRATION: Decompressive Hemicraniectomy Combined Hypothermia in Malignant Middle Cerebral Artery Infarct, ChiCTR-TRC-12002698. Registered 11 Oct 2012- Retrospectively registered, URL: http://www.chictr.org.cn/showproj.aspx?proj=6854 .

Entities:  

Keywords:  Decompressive craniectomy; Large hemispheric infarction; Neurological outcome; Randomized controlled trial; Target temperature management

Mesh:

Year:  2021        PMID: 33711963      PMCID: PMC7953537          DOI: 10.1186/s12883-021-02142-7

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  27 in total

1.  'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

Authors:  W Hacke; S Schwab; M Horn; M Spranger; M De Georgia; R von Kummer
Journal:  Arch Neurol       Date:  1996-04

2.  Improved Neurological Outcome With Mild Hypothermia in Surviving Patients With Massive Cerebral Hemispheric Infarction.

Authors:  Yingying Su; Linlin Fan; Yunzhou Zhang; Yan Zhang; Hong Ye; Daiquan Gao; Weibi Chen; Gang Liu
Journal:  Stroke       Date:  2015-12-22       Impact factor: 7.914

3.  Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant Middle Cerebral Artery Stroke: A Randomized Clinical Trial.

Authors:  Hermann Neugebauer; Hauke Schneider; Julian Bösel; Carsten Hobohm; Sven Poli; Rainer Kollmar; Jan Sobesky; Stefan Wolf; Miriam Bauer; Sascha Tittel; Jan Beyersmann; Johannes Woitzik; Peter U Heuschmann; Eric Jüttler
Journal:  JAMA Neurol       Date:  2019-05-01       Impact factor: 18.302

4.  Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old.

Authors:  Jingwei Zhao; Ying Ying Su; Yan Zhang; Yun Zhou Zhang; Ruilin Zhao; Lin Wang; Ran Gao; Weibi Chen; Daiquan Gao
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

5.  Adjunctive functional pharyngeal electrical stimulation reverses swallowing disability after brain lesions.

Authors:  Vanoo Jayasekeran; Salil Singh; Pippa Tyrrell; Emilia Michou; Samantha Jefferson; Satish Mistry; Ed Gamble; John Rothwell; David Thompson; Shaheen Hamdy
Journal:  Gastroenterology       Date:  2010-02-02       Impact factor: 22.682

6.  Glibenclamide enhances the effects of delayed hypothermia after experimental stroke in rats.

Authors:  Zhou Wu; Shu-Zhen Zhu; Ya-Fang Hu; Yong Gu; Sheng-Nan Wang; Zhen-Zhou Lin; Zuo-Shan Xie; Su-Yue Pan
Journal:  Brain Res       Date:  2016-04-28       Impact factor: 3.252

Review 7.  Effects of hypothermia on energy metabolism in Mammalian central nervous system.

Authors:  Maria Erecinska; Marianne Thoresen; Ian A Silver
Journal:  J Cereb Blood Flow Metab       Date:  2003-05       Impact factor: 6.200

8.  Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke.

Authors:  J Marc Simard; Natalia Tsymbalyuk; Orest Tsymbalyuk; Svetlana Ivanova; Vladimir Yurovsky; Volodymyr Gerzanich
Journal:  Stroke       Date:  2010-01-21       Impact factor: 7.914

9.  Surgical decompression for space-occupying cerebral infarction: outcomes at 3 years in the randomized HAMLET trial.

Authors:  Marjolein Geurts; H Bart van der Worp; L Jaap Kappelle; G Johan Amelink; Ale Algra; Jeannette Hofmeijer
Journal:  Stroke       Date:  2013-07-18       Impact factor: 7.914

10.  Safety and Efficacy of Hypothermia (34°C) after Hemicraniectomy for Malignant MCA Infarction.

Authors:  Hyun-Seok Park; Jae-Hyung Choi
Journal:  J Korean Neurosurg Soc       Date:  2018-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.